Show Cart

Antibodies

13 Jul 2007 Phase II Study of IMC-A12 for Advanced Colorectal Cancer Has Commenced Patient Enrollment
12 Jul 2007 Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Lung Cancer Patients
12 Jul 2007 TRACON Pharmaceuticals and Micromet Announce the Initiation of Phase 1 Clinical Trial with TRC093 (D93), a Humanized Antibody for Cancer Treatment
11 Jul 2007 Actemra: latest phase III study shows significant improvement in symptoms of patients with rheumatoid arthritis
11 Jul 2007 Peregrine Pharmaceuticals Initiates Bavituximab Clinical Trial in HCV Patients Co-Infected With HIV
10 Jul 2007 MacroGenics IND for West Nile Virus Monoclonal Antibody is Active
03 Jul 2007 Ablynx announces interim results of first nanobody (R) phase i study of ALX-0081 (anti-vWF)
03 Jul 2007 Lexicon Develops Antibodies that Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
02 Jul 2007 Genmab announces final humax-CD4 Phase II CTCL data
30 Jun 2007 Genmab regains rights to HuMax-CD4
30 Jun 2007 WILEX to follow FDA advice and apply for a special protocol assessment (SPA) for CA9-SCAN
23 Jun 2007 Alexion's Soliris(TM) granted marketing approval in europe for treatment of all patients with PNH
22 Jun 2007 Viragen Streamlines Research Focus and Halts Further Development of OVA(TM) System
20 Jun 2007 Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
19 Jun 2007 Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology
16 Jun 2007 Actemra: Roche's novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study
16 Jun 2007 GlaxoSmithKlline and Genmab present positive Phase II results with ofatumumab in patients with rheumatoid arthritis (RA)
16 Jun 2007 GlaxoSmithKlline and Genmab present positive Phase II results with ofatumumab in patients with rheumatoid arthritis (RA)
16 Jun 2007 Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia(R) (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
15 Jun 2007 Anti-TNF golimumab continues to show promise in Phase II rheumatoid arthritis study
15 Jun 2007 CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
15 Jun 2007 Human Genome Sciences reports that a Phase 2 study of LymphoStat-B(R) showed significant reductions in disease activity in patients with active systemic lupus erythematosus
15 Jun 2007 Algeta demonstrates targeted cancer-killing potential of novel alpha particle linked antibodies in leading medical journal Blood
15 Jun 2007 Genmab initiates ofatumumab frontline NHL study
14 Jun 2007 ENBREL Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Recommended Report

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Recommended Report

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top